Neurodegenerative Disease Technologies

Bi-specific Antibodies as a Therapeutic for Alzheimer’s Disease

Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments

Compounds to Modulate Retinoid X Receptors

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

High-resolution Flexible Neural Implant

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors